Scars – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Scars Market Outlook

Thelansis’s “Scars Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Scars treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Scars Overview

Scars are a natural part of the body's healing process. They are made up of collagen, a protein that helps to repair damaged tissue. Scars can vary in appearance depending on the injury's severity, the scar's location, and the person's skin type. Some scars are flat and fade over time; others are raised, red, and itchy. Scars can be caused by:

• Injuries: Cuts, scrapes, burns, and other injuries can all cause scars.
• Surgery: Surgery often leaves scars.
• Skin conditions: Some skin conditions, such as acne and chickenpox, can cause scars.
• Medical conditions: Some medical conditions, such as keloids and hypertrophic scars, can cause abnormal scar tissue to form.

There are five main types of scars:

1. Fine-line scars: These are the most common type of scar caused by minor wounds that heal without complications. They are usually raised at first but gradually fade and flatten over time.
2. Keloid scars: These scars are caused by an overgrowth of scar tissue. They are raised, red, and can be itchy or painful. Keloid scars can extend beyond the boundaries of the original wound.
3. Hypertrophic scars: These scars are similar to keloid scars but do not extend beyond the boundaries of the original wound. They are raised and red but not usually as itchy or painful as keloid scars.
4. Pitted or sunken scars: These are caused by losing underlying fat or tissue. They can be caused by acne, chickenpox, or other skin conditions.
5. Scar contractures: These scars are caused by the skin "shrinking" after an injury. They can restrict movement and can be painful.

The type of scar you develop will depend on your injury's severity, genetics, and skin type. There are treatments available for some types of scars, such as laser therapy, steroid injections, and silicone sheets. The main risk factors include age, allergic predisposition, bacterial colonization within the wound (with or without infection), and cutaneous tension. Most hypertrophic scars are commonly observed in individuals aged 11 to 30 years. This trend can be attributed to looser skin and a diminished inflammatory response as one age.

• The estimation suggests that over half of the patients express dissatisfaction with the way their scars look, with around 20% experiencing anxiety and a majority of over 50% indicating that the presence of their scars impacts their sense of privacy.

Geography Covered:

North America- the United States and Canada

Europe- EU5 (Germany, France, Italy, Spain, and the United Kingdom)

Other countries- Japan & China

Study Period: 2022-2032

Current Clinical Practice and Treatment Algorithm

This section of the study covers country-specific current clinical practice, the standard of care, and significant limitations around addressing the unmet needs. Retrospective analysis and bench-marking of clinical study outcomes are presented in terms of Pre-treatment & post-treatment clinical and demographic patient characteristics. Essentially, this section will cover the evolution of the current competitive landscape and its impact on the future treatment paradigm.

KOL Insights:

KOLs across 8 MM markets from the center of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs

Market Forecast: Patient Based Forecast Model (MS. Excel Based Automated Dashboard)

- Data Inputs with sourcing

- Market Event and Product Event

- Country-specific Forecast Model

- Market uptake and patient share uptake

- Attribute Analysis

- Analog Analysis

- Disease burden and pricing scenario

- Summary and Insights

NPV/ IRR Calculator-

Optimization of cash flow/ revenue flow concerning all fixed and variable investments throughout the product development process. The rate of return on an investment is a critical indicator to ensure the profitability and break-even of the project.

Competitive Landscape:

The competitive landscape includes country-specific approved as well as pipeline therapies. Any asset/product-specific designation or review such as Orphan drug designation, Fast track, Priority Review, Breakthrough Therapy Designation, Rare Pediatric Disease Designation, and Accelerated Approval are tracked and supplemented with analyst commentary.

Clinical Trial Assessment-

Detailed clinical trial data analysis and critical product positioning include trial design, primary outcomes, secondary outcomes, dosing and schedules, inclusion and exclusion criteria, recruitment status and essentially covers the reported adverse events. Majorly the trial analysis helps determine the potential of the critical assets and their probable filing and launch date.

Unmet Medical Needs Overview-

This report presents the most important clinical unmet needs in the treatment, according to Thelansis research and analysis. Other essential unmet needs identified through our study include decreased cost burden on patients, improved administration convenience, and improved patient compliance.

Visit our social media pages: